NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Peter Feldschreiber, MBBS, LLB, Barrister at Law

Practice Area Focus

  • Drug Development Strategy
  • Regulatory Strategy
  • EU Food & Drug Law
  • Health Technology Assessment
  • Clinical Pharmacology


Peter Feldschreiber is dually qualified as a barrister and physician. He specializes and advises in all aspects of medical and healthcare law including healthcare products liability, pharmaceutical and medical devices regulatory law, clinical negligence, personal injury, and medically related employment litigation. He has held appointments as Senior Medical Assessor and Special Litigation Coordinator to the Commission on Human Medicines, Medicines and Healthcare Products Regulatory Agency (MHRA), Department of Health. Dr. Feldschreiber serves on the Committee of Safety of Devices and the Code of Conduct Committee of the Association of British Health Industry. He was formerly a Medical Director, Cardiovascular and Anaesthetic clinical development at Glaxo Pharmaceuticals, and Medical Director Europe, Procter and Gamble. He has lectured and written extensively on pharmaceutical law and regulation, is General Editor of the Law and regulation of Medicines (Oxford University Press), and is consultant editor to Halsbury's Laws of England on Medicinal Products Law.

"He is an excellent analyst who is able to unpick very technical information and put it into clear English. He's very responsive and client-friendly. A joy to work with."
Chambers Directory of the UK Bar 2014

"I shall expect when I sit in Court to see not only the barristers and solicitors but the clients sitting with a copy of Feldschreiber open in front of them. But more important, I suspect that the regulator and the drug developer too will keep this book close at hand."
Mr. Justice Burton, Foreword to the Law and Regulation of Medicines